JACKSONVILLE, Fla.--(BUSINESS WIRE)--Novabone Products, a medical device company, announces the release of NovaBone Bioactive Strip®, its third technology platform provided to the orthopedic community based on the combination of bioactive glass and bovine collagen.
NovaBone Bioactive Strip® is a bone graft composed of purified fibrillar collagen and resorbable bioactive synthetic morsels. The open structure allows for rapid vascularization and mineralization and permits complete device absorption and replacement by new bone. The compression resistant, formable and moldable bone graft creates a highly Osteoconductive Matrix for new bone growth. The strip’s optimal composition and pore size is designed to mimic cancellous bone.
"This past September, we announced the launch of MacroFORM Packable Graft and MacroFORM Composite. Both of those products are designed to be hydrated with bone marrow aspirate and then molded into a putty type format and were the first of a new bioactive collagen line designed for use in orthopedic surgeries,” said Art Wotiz, President of NovaBone Products. “We feel the strip will be well-received because of its ability to absorb and retain bone marrow aspirate while it remains to be easy to handle and place.”
The new Novabone Bioactive Strip® is 95% bioglass dispersed in a collagen matrix in a preformed shape that is cross linked using a proprietary process that avoids the use of aldehydes alleviating any concern of residual aldehyde contamination. After hydration with bone marrow aspirate, the cross linked device retains its shape even after manipulation.
Novabone Products also offers a complete line of bioactive products designed to be used as packaged with no manipulation required. These ready-to-use products include Novabone Bioactive Synthetic Putty®, Novabone Bioactive Synthetic Putty MIS Cartridge Delivery System®, Novabone MacroPor Si+ Bioactive Bone Graft®, Novabone OS - Si+ Morsels Porous Synthetic Bone Graft®, and Novabone Osteostimulative Morsels®. Both families of products, ready to use and bone marrow aspirate friendly, are manufactured in Novabone's Alachua, Florida facility.
"We are very proud to provide a complete and diverse portfolio of bone grafting options to surgeons. We have established core competencies in designing and manufacturing bioactive glass products delivered in a variety of delivery systems to meet surgeons' needs such as collagen and ready to use putties," Wotiz concluded.
About Novabone Products:
NovaBone Products was established in 2002 with a focus on developing bone graft substitutes based on advancements in biomedical engineering that would meet the specialized needs of orthopedic and dental surgeons.
Since its inception, our company has developed numerous formulations and delivery systems of its patented, bioactive technology platform that results in accelerated bone growth. In total, our exclusively formulated bone graft substitute has been used for the repair of osseous defects throughout the skeletal system for over a decade and used in over a million clinical applications with unparalleled success validating the safety and efficacy of NovaBone's technology.
NovaBone® was the first bioactive synthetic bone graft offered to the orthopedic community; the unique properties of the product formulation gave rise to the need to scientifically define its bone-forming process, and in 2005, the FDA authorized the term “osteostimulation,” as a way to describe how our products signal genetic pathways to accelerate natural regeneration of bone.
